K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42: S1-201.
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69:1945-1953.
Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD work group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009;6:S1-130.
Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int 1993;43:436-442
Barretto FC, Barreto DV, Moyses RM, Neves KR, Canziani ME, Dralbe SA, et al. K/DOQI-recommended intact PTH levels do not prevent low turnover bone disease in hemodialysis patients. Kidney Int 2008;73:771-777
Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218
Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780.
Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006;70:345-350
Mithal A, Wahl A, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20:1807-1820
Nussbaum S, Zahradnik R, Lavigne J, Brennan G, Nozawa- Ung K, Kim L, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-1367
Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S, Göhring U, et al. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 1988;67:353-360
Endres D, Villanueva R, Sharp Jr C, Singer F. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991;37:162-168
Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, et al. Vitamin D status and redefining serum parathyroid hormone reference range. J Clin Endocrinol Metab 2001;86:3086-3090
Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:340-350
Monge M, Jean G, Bacri JL, Masy E, Joly D, Souberbielle JC. Higher parathyroid hormone (PTH) concentrations with the architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods. Clin Chem Lab Med 2009;47:362-366
Cavalier E, Delanaye P, Chapelle JP, Souberbielle JC. Vitamin D: current status and perspectives. Clin Chem Lab Med 2009; 47:120-127
Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009;24:3799-3805
Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Gao P, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-761
Gao P, Scheibel S, D'Amour P, John M, Rao S, Schmidt-Gayk H, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implication for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001;16:605-614
Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai G, et al. PTH 1-84 and PTH ''7-84'' in the non-invasive diagnosis of bone disease. Am J Kidney Dis 2002;40:348-354
Salusky I, Goodman W, Kuizon B, Lavigne J, Zahranik R, Gales B, et al. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 2003; 63:1801-1808
Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman W. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 2005;68:1206-1214
Melamed M, Eustace J, Plantinga L, Jaar B, Fink N, Parekh R, et al. Third-generation parathyroid hormone assays and allcause mortality in incident dialysis patients: the CHOICE study. Nephrol Dial Transplant 2008;23:1650-1658
Souberbielle JC, Roth H, Fouque D. Parathyroid measurement in CKD. Kidney Int 2010;77:93-100.
Joly D, Drueke T, Alberti C, Houillier P, Lawson-Body E, Martin KJ, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 2008;51:987-995
Twoney PJ, Whitlock T, Pledger DR. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. J Clin Pathol 2005;58:1000-1001
Holmes DT, Levin A, Forer B, Rosenberg F. Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem 2005;51:915-917
Glendenning P, Musk A, Taranto M, Vasikaran S. Preanalytical factors in the measurement of intact parathyroid hormone with the DPC Immulite assay. Clin Chem 2002;48:566-567
Cavalier E, Delanaye P, Carlisi A, Krzesinsky JM, Chapelle JP. Stability of parathyroid hormone in samples from hemodialysis patients. Kidney Int 2007;72:370-372
Parent X, Alenabi F, Brignon P, Souberbielle JC. Delayed measurement of PTH in patients with CKD: storage of the primary tube in the dialysis unit, which temperature? Which kind of tube? warticle in Frenchx. Nephrol Ther 2009;5:34-40.
Cavalier E, Delanaye P, Hubert P, Krzesinski JM, Chapelle JP, Rozet E. Estimation of the stability of parathyroid hormone when stored at -808C for a long period. Clin J Am Soc Nephrol 2009;4:1988-1992
